Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
ET-1402 by Eureka Therapeutics for Hepatocellular Carcinoma: Likelihood of Approval
ET-1402 is under clinical development by Eureka Therapeutics and currently in Phase II for Hepatocellular Carcinoma. According to GlobalData, Phase...